---
schema_version: "secwatch.filing_event.v1"
accession: "0001932393-25-000007"
form_type: "8-K"
ticker: "GEHC"
cik: "0001932393"
company_name: "GE HealthCare Technologies Inc."
filed_at: "2025-03-31T23:59:59+00:00"
generated_at: "2026-05-24T02:31:29.242461+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# GE HealthCare refinances credit facilities: $3.0B revolver and $0.5B 364-day facility replace prior agreements

## Summary
- New $3.0B revolving credit facility matures March 27, 2030; new $0.5B 364-day facility matures March 26, 2026.
- Replaces prior $2.5B revolving facility (November 2022) and $1.0B 364-day facility (December 2024), both terminated March 27, 2025.
- JPMorgan Chase Bank, N.A. named administrative agent (previously Citibank). Interest rate based on SOFR/EURIBOR/SONIA plus margin tied to credit ratings.
- Covenants include limits on liens, fundamental changes, leverage ratio, and non-guarantor subsidiary indebtedness.

## SEC filing metadata
- accession: 0001932393-25-000007
- form_type: 8-K
- ticker: GEHC
- cik: 0001932393
- company_name: GE HealthCare Technologies Inc.
- filed_at: 2025-03-31T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/0001932393-25-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/gehc-20250327.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001932393-25-000007
- JSON: https://secwatch.observer/filing/0001932393-25-000007.json
- Plain text: https://secwatch.observer/filing/0001932393-25-000007.txt

## Key facts
- Debt Financings
  GE HealthCare Technologies Inc. incurred revolving credit of $3.0 billion with JPMorgan Chase Bank, N.A. at alternate base rate or an adjusted Term SOFR rate for a one-, three-, or six-mon maturing March 27, 2030.
  - Instrument: revolving credit
  - Principal: $3.0 billion
  - Counterparty: JPMorgan Chase Bank, N.A.
  - Rate: alternate base rate or an adjusted Term SOFR rate for a one-, three-, or six-mon
  - Maturity: March 27, 2030
  - Event: incurrence
  source text: Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a senior unsecured revolving credit facility in an aggregate committed amount of $3.0 billion. The 2025 Credit Agreement and the 2025 364-Day Revolving Credit Agreement are each referred to herein as a “New Credit Agreement” and collectively as the “New Credit
  evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/0001932393-25-000007-index.htm
- Debt Financings
  GE HealthCare Technologies Inc. incurred revolving credit of $0.5 billion with JPMorgan Chase Bank, N.A. at alternate base rate or an adjusted Term SOFR rate for a one-, three-, or six-mon maturing March 26, 2026.
  - Instrument: revolving credit
  - Principal: $0.5 billion
  - Counterparty: JPMorgan Chase Bank, N.A.
  - Rate: alternate base rate or an adjusted Term SOFR rate for a one-, three-, or six-mon
  - Maturity: March 26, 2026
  - Event: incurrence
  source text: Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion, and (ii) a Credit Agreement (the “2025 Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides
  evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000193239325000007/0001932393-25-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.